Showing results (321-330 of 339) with videos related to
Sort By:
Pageof 34
Cell Host & Microbe|June 7, 2020
A Combination of Human Broadly Neutralizing Antibodies against Hepatitis B Virus HBsAg with Distinct Epitopes Suppresses Escape MutationsQiao Wang, Eleftherios Michailidis, Yingpu Yu, et al.Immunity|September 13, 2016
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing AntibodiesJon M Steichen, Daniel W Kulp, Talar Tokatlian, et al.Pharmaceutics|May 25, 2024
Impact of LS Mutation on Pharmacokinetics of Preventive HIV Broadly Neutralizing Monoclonal Antibodies: A Cross-Protocol Analysis of 16 Clinical Trials in People without HIVBryan T Mayer, Lily Zhang, Allan C deCamp, et al.Annals of the New York Academy of Sciences|August 23, 2018
Sm-p80-based schistosomiasis vaccine: double-blind preclinical trial in baboons demonstrates comprehensive prophylactic and parasite transmission-blocking efficacyWeidong Zhang, Adebayo J Molehin, Juan U Rojo, et al.Epilepsy & Behavior : E&B|March 25, 2008
The Wada test in Austrian, Dutch, German, and Swiss epilepsy centers from 2000 to 2005: a review of 1421 proceduresA Haag, S Knake, H M Hamer, et al.Nature Immunology|August 16, 2011
Repression of the genome organizer SATB1 in regulatory T cells is required for suppressive function and inhibition of effector differentiationMarc Beyer, Yasser Thabet, Roman-Ulrich Müller, et al.Blood|December 28, 2020
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trialSilke Kapp-Schwoerer, Daniela Weber, Andrea Corbacioglu, et al.Scientific Reports|December 29, 2019
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vectorM Giel-Moloney, M Esteban, B H Oakes, et al.Immunity|September 18, 2020
A Potent Anti-Malarial Human Monoclonal Antibody Targets Circumsporozoite Protein Minor Repeats and Neutralizes Sporozoites in the LiverLawrence T Wang, Lais S Pereira, Yevel Flores-Garcia, et al.Nature Communications|December 14, 2023
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trialsDaniel B Reeves, Bryan T Mayer, Allan C deCamp, et al.Pageof 34